t 593 has been researched along with pentagastrin in 1 studies
| Studies (t 593) | Trials (t 593) | Recent Studies (post-2010) (t 593) | Studies (pentagastrin) | Trials (pentagastrin) | Recent Studies (post-2010) (pentagastrin) |
|---|---|---|---|---|---|
| 14 | 0 | 1 | 3,639 | 207 | 51 |
| Protein | Taxonomy | t 593 (IC50) | pentagastrin (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.8875 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Inoie, M; Marubuchi, S | 1 |
1 other study(ies) available for t 593 and pentagastrin
| Article | Year |
|---|---|
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |